The Globe and Mail reports in its Tuesday, Aug. 15, edition that Stifel analyst Martin Landry has reaffirmed his "buy" recommendation for Park Lawn. The Globe's David Leeder writes in the Eye On Equities column that Mr. Landry gave his share target a $2 trim to $32. Analysts on average target the shares at $32.50. Mr. Landry says in a note: "Park Lawn reported Q2/23 results which were in-line with expectations. Market share gains continued for a fourth consecutive quarter with Q2/23 call volumes down 2 per cent vs industry volumes down 3 per cent. Elevated death rates, which have caused fluctuations in at-need revenues in H1/23, appear to be abating. However, management continues to expect a decline in mortality throughout 2023, which will likely lead to lower call volumes than previously expected. Additionally, cemetery sales appear softer than expected. This combined with a difficult year-over-year comparable in H2/23, could continue to pressure comparable revenue growth in the second half of the year. On a positive side, Park Lawn's acquisition pipeline looks healthy as the company remains on track to spend between $75-million to $125-million on acquisitions this year."